These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9503043)

  • 21. Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
    Galan P; Briançon S; Favier A; Bertrais S; Preziosi P; Faure H; Arnaud J; Arnault N; Czernichow S; Mennen L; Hercberg S
    Br J Nutr; 2005 Jul; 94(1):125-32. PubMed ID: 16115341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study.
    Hercberg S; Kesse-Guyot E; Druesne-Pecollo N; Touvier M; Favier A; Latino-Martel P; Briançon S; Galan P
    Int J Cancer; 2010 Oct; 127(8):1875-81. PubMed ID: 20104528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population.
    Galan P; Viteri FE; Bertrais S; Czernichow S; Faure H; Arnaud J; Ruffieux D; Chenal S; Arnault N; Favier A; Roussel AM; Hercberg S
    Eur J Clin Nutr; 2005 Oct; 59(10):1181-90. PubMed ID: 16034362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study.
    Hercberg S; Czernichow S; Galan P
    Br J Nutr; 2006 Aug; 96 Suppl 1():S28-30. PubMed ID: 16923246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
    Houston MC
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
    Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
    J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults.
    Czernichow S; Vergnaud AC; Galan P; Arnaud J; Favier A; Faure H; Huxley R; Hercberg S; Ahluwalia N
    Am J Clin Nutr; 2009 Aug; 90(2):329-35. PubMed ID: 19491388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of computerised 24 h dietary recalls in the French SU.VI.MAX Study: number of recalls required.
    Mennen LI; Bertrais S; Galan P; Arnault N; Potier de Couray G; Hercberg S
    Eur J Clin Nutr; 2002 Jul; 56(7):659-65. PubMed ID: 12080407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical activity does not influence the effect of antioxidant supplementation at nutritional doses on the incidence of impaired fasting glucose: a 7.5 year post-hoc analysis from the SU.VI.MAX study.
    Fezeu L; Henegar A; Kesse-Guyot E; Julia C; Galan P; Hercberg S; Ristow M; Czernichow S
    Horm Metab Res; 2010 Oct; 42(11):826-7. PubMed ID: 20665424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
    Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
    J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of 6-year body weight change on cardiac geometry and function in ageing adults: the SUpplémentation en Vitamines et Minéraux AntioXydants -2 (SU.VI.MAX-2) cardiovascular ultrasound substudy.
    Monsuez JJ; Kesse-Guyot E; Fezeu L; Blacher J; Galan P; Sebbane G; Hercberg S; Czernichow S
    J Hypertens; 2010 Nov; 28(11):2309-15. PubMed ID: 20706135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
    Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
    J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health].
    Hercberg S
    Ann Pharm Fr; 2006 Nov; 64(6):397-401. PubMed ID: 17119469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary patterns and their sociodemographic and behavioural correlates in French middle-aged adults from the SU.VI.MAX cohort.
    Kesse-Guyot E; Bertrais S; Péneau S; Estaquio C; Dauchet L; Vergnaud AC; Czernichow S; Galan P; Hercberg S; Bellisle F
    Eur J Clin Nutr; 2009 Apr; 63(4):521-8. PubMed ID: 18212801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation.
    Ezzedine K; Latreille J; Kesse-Guyot E; Galan P; Hercberg S; Guinot C; Malvy D
    Eur J Cancer; 2010 Dec; 46(18):3316-22. PubMed ID: 20605091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a role for supplemented antioxidants in the prevention of atherosclerosis?
    Katsiki N; Manes C
    Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary antioxidant intake in patients at risk for second primary cancer.
    Steward DL; Wiener F; Gleich LL; Falciglia G
    Laryngoscope; 2003 Sep; 113(9):1487-93. PubMed ID: 12972921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Czernichow S; Hercberg S
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2269-72. PubMed ID: 16172243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.